Search results for "Ambroxol"

showing 2 items of 2 documents

Real World Evidence data – pharmacy base survey on different patient profils characterisation and therapeutic responses for ambroxol in the OTC setti…

2018

Pulmonary and Respiratory Medicinebusiness.industryAmbroxolMedicinePharmacyMedical emergencybusinessBase (topology)medicine.diseaseReal world evidencemedicine.drugPneumologie
researchProduct

False-positive LSD testing in urine samples from intensive care patients.

1998

Unexpected positive results for lysergic acid diethylamide (LSD) were found in urine samples from 12 patients in an intensive care unit in a routine screening using the CEDIA DAU assay. None of these test results could be confirmed by high-performance liquid chromatography analysis, but all samples contained the mucolytic drug ambroxol. Further studies demonstrated that ambroxol exhibits a significant cross-reactivity in the CEDIA DAU LSD assay. Therefore, positive LSD results obtained with the CEDIA DAU assay have to be critically evaluated, particularly during the cold season, when infections of the respiratory tract often result in more frequent use of mucolytic medications.

HallucinogenAdultMalemedicine.medical_specialtyHealth Toxicology and MutagenesisAmbroxolUrineCross ReactionsToxicologyHigh-performance liquid chromatographyGastroenterologyAnalytical Chemistrylaw.inventionlawIntensive careInternal medicinemedicineEnvironmental ChemistryHumansFalse Positive ReactionsChromatography High Pressure LiquidLysergic acid diethylamideAgedExpectorantsAged 80 and overImmunoassayChemical Health and SafetyChromatographymedicine.diagnostic_testChemistryIntensive care unitAmbroxolIntensive Care UnitsLysergic Acid DiethylamideImmunoassayHallucinogensFemaleReagent Kits Diagnosticmedicine.drugJournal of analytical toxicology
researchProduct